Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Reproductive Technologies, Inc.
FDA Inspection
•Reproductive Technologies, Inc.•August 16, 2019

Reproductive Technologies, Inc. – FDA Inspection, Aug 16, 2019

Record Details

This FDA Inspection record concerns Reproductive Technologies, Inc., with an inspection on August 16, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Reproductive Technologies, Inc.
Inspection Date
August 16, 2019
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Yvonne C. Wilkes (Company Rep)
View Company Profile

ID · 57e50f00-bfa5-4927-a5b1-3888f3de498b

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1100185
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

4
  1. 21 CFR 1271.75(d)Donors with risks not determined ineligible
  2. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  3. 21 CFR 1271.47(a)Design of procedures to ensure compliance
  4. 21 CFR 1271.55(b)(2)Listing and interpretation of CD tests performed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Reproductive Technologies, Inc.

6
DateClassificationOfficeProject area
November 18, 2024VAISan Francisco District OfficeHuman Cellular, Tissue, and Gene Therapies
September 13, 2021NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 8, 2016NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
December 20, 2013NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
February 17, 2012NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
View all 6 other inspections on the company page
Other documents for Reproductive Technologies, Inc.
  • FDA Inspection 1254426 - 2024-11-18
  • FDA Inspection 1153089 - 2021-09-13
  • FDA Inspection 983894 - 2016-09-08
  • FDA Inspection 861157 - 2013-12-20
  • FDA Inspection 768779 - 2012-02-17

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Reproductive Technologies, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.